Results 111 to 120 of about 50,725 (308)

RHEUMATIC HEART DISEASE OUTCOME BETWEEN MITRAL VALVE REGURGITATION AND MITRAL VALVE PROLAPSE

, 2020
Objectives: To assess the most common valvular diseases presented in patients with RHD and associated complications. Methodology: a cross sectional observational study was conducted from (dates), at (setting), for a duration of six months. All patients over the age of 18 years with diagnosed rheumatic heart disease who presented in the out patients ...
openaire   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

The impact of sub-valvular apparatus preservation on prosthetic valve dysfunction during mitral valve replacement

Research in Cardiovascular Medicine, 2013
Background: Sub-valvular apparatus preservation (SAP) during mitral valve replacement (MVR) is not a new concept. Some surgeons prefer to excise the apparatus.
Alireza Alizadeh-Ghavidel, Yalda Mirmesdagh, Mehrzad Sharifi, Anita Sadeghpour, Reza Nakhaeizadeh, Gholamreza Omrani   +5 more
doaj   +1 more source

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk, Ewa Dziewięcka, Sylwia Wiśniowska‐Śmiałek, Agnieszka Stępień, Katarzyna Graczyk, Agata Leśniak‐Sobelga, Marta Hlawaty, Jakub Woźniak, Maryia Savitskaya, Katarzyna Holcman, Magdalena Kostkiewicz, Piotr Podolec, Paweł Rubiś   +12 more
wiley   +1 more source

Clinical case of acute chord rupture of the mitral valve posterior leaflet in older patient with comorbidities [PDF]

, 2015
The article describes the etiologic role of various factors such as chronic rheumatic heart disease, bacterial endocarditis, aortic valve stenosis, hypertension, coronary heart disease, including acute myocardial infarction, degenerative disease of the ...
Kramarenko, I. A., Kuznetsov, I. V., Lopin, D. O., Lopina, N. A., Zhuravlyova, L. V.   +4 more
core   +1 more source

Midterm outcomes of mechanical versus bioprosthetic valve replacement in middle-aged patients: An Indian scenario

Heart India, 2017
Objective: The goal of this study is to evaluate and compare the midterm outcomes of bioprosthetic heart valve replacement in terms of survival, valve-related events, quality of life, and economic aspects of treatment in population age 45 years and above
Dheeraj Sharma, Anula Sisodia, Sanjeev Devgarha, Rajendra Mohan Mathur   +3 more
doaj   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Starr-Edwards Mechanical Prosthesis for More Than 53 Years in the Mitral Position: A Case Report

International Journal of the Cardiovascular Academy
Valvular heart disease affects approximately 2.5% of the global population. Starr-Edwards (SE) prosthetic valves are commonly used in the aortic and mitral positions, with reported durability extending up to 40 years.
Roberto Carlos Macías Cervantes, Luis Miguel Alfonso Fernandez Gutierrez, Enrique Arana Martínez   +2 more
doaj   +1 more source

Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1256-1270, April 2025.
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li, Max Homilius, Erin Achilles, Laura K. Massey, Victoria Convey, Åsa Ohlsson, Ingrid Ljungvall, Jens Häggström, Brittany Vester Boler, Pascal Steiner, Sharlene Day, Calum A. MacRae, Mark A. Oyama   +12 more
wiley   +1 more source

Computation of incompressible viscous flows through artificial heart devices with moving boundaries [PDF]

The extension of computational fluid dynamics techniques to artificial heart flow simulations is illustrated. Unsteady incompressible Navier-Stokes equations written in 3-D generalized curvilinear coordinates are solved iteratively at each physical time ...
Chang, I.-DEE, Kiris, Cetin, Kwak, Dochan, Rogers, Stuart   +3 more
core   +1 more source